Volume 30 - Number 8 | February 2012
| February Issue in PDF Format … |
| The FDA’s New Guidelines on Financial Disclosure by Clinical Investigators By Christiana C. Jacxsens and Jessica C. Cabral The FDA has recently updated its Guidance for Industry: Financial Disclosure of Clinical Investigators for the first time since 2001. This article briefly examines the key changes and their practical implications in product liability cases. |
| Practice Tip: Product Liability Litigation By Chris DePhillips and Todd Richheimer Although recent statistics are difficult to obtain, it is clear that the amount of product liability litigation filed in the United States is unparalleled around the world. hy is there such a difference as compared with Canada and the UK? |
| Lies, Damned Lies, and Addictions By David L. Wallace This three-part article explores the role of addiction in product liability litigation, and the paradoxes involved. |
